Feed-forward inhibition: a novel cellular mechanism for the analgesic effect of substance P by Wu, Long-Jun et al.
BioMed  Central
Page 1 of 4
(page number not for citation purposes)
Molecular Pain
Open Access Commentary
Feed-forward inhibition: a novel cellular mechanism for the 
analgesic effect of substance P
Long-Jun Wu, Hui Xu, Shanelle W Ko, Megumu Yoshimura and Min Zhuo*
Address: Department of Physiology, Faculty of Medicine, University of Toronto, University of Toronto Centre for the Study of Pain, Medical Science 
Building, 1 King's College Circle, Toronto, Ontario M5S 1A8, Canada
Email: Long-Jun Wu - longjun.wu@utoronto.ca; Hui Xu - hui.xu@utoronto.ca; Shanelle W Ko - shana.ko@utoronto.ca; 
Megumu Yoshimura - yoshimum@physiol.med.kyushu-u.ac.jp; Min Zhuo* - min.zhuo@utoronto.ca
* Corresponding author    
Abstract
Substance P (SP) is a neuropeptide well known for its contribution to pain transmission in the spinal
cord, however, less is known about the possible modulatory effects of SP. A new study by Gu and
colleagues, published in Molecular Pain (2005, 1:20), describes its potential role in feed-forward
inhibition in lamina V of the dorsal horn of the spinal cord. This inhibition seems to function through
a direct excitation of GABAergic interneurons by substance P released from primary afferent fibers
and has a distinct temporal phase of action from the well-described glutamate-dependent feed-
forward inhibition. It is believed that through this inhibition, substance P can balance nociceptive
output from the spinal cord.
The spinal cord dorsal horn is one of the relay stations for
nociceptive information transmitted by peripheral sen-
sory afferents. Some of these sensory afferents are sub-
stance P (SP) and glutamate-containing Aδ- and C- fibers.
Upon noxious stimulation, particularly intense stimula-
tion, tachykinins such as SP and neurokinin A (NKA) are
released from primary afferent fibers and excite dorsal
horn neurons via activation of the neurokinin-1 and neu-
rokinin-2 receptors (NK1R and NK2R), respectively [1,2].
A series of studies have established a role for SP in the
transmission of pain information [3,4]. Mice genetically
engineered not to express the precursor of SP [4] and mice
that do not express SP's target, the NK1R [3], both display
reduced responses to painful stimuli. Despite these prom-
ising initial findings, NK1R antagonists have failed to pro-
duce analgesia in a variety of clinical pain models [5]. One
possible explanation for these inconsistent results is that
SP may produce mixed effects in sensory-related transmis-
sion and modulation. Indeed, Mohrland and Gebhart
reported that an intrathecal injection of SP had antinocic-
eptive effects [6]. Similarly, a study has found an analgesic
effect mediated by SP and further suggested that it might
be mediated by µ-2 opioid receptors [7]. Other studies
demonstrate an interaction between tachykinin and opi-
oid systems, lending support for a role of opioid receptors
in SP-mediated antinociception [8].
Although many studies have highlighted the importance
of SP in pain transmission, the synaptic mechanisms
underlying the antinociceptive effect of SP remain
unclear. In a recent study published in Molecular Pain, Gu
and colleagues used a combination of electrophysiologi-
cal, pharmacological, genetic and behavioral techniques
in rats and found that SP can modulate inhibitory trans-
mission in lamina V of the spinal cord dorsal horn,
thereby exerting an analgesic effect on nociceptive sensory
processing [9]. Through this finding, the study provides
novel insight into the role of SP in the spinal cord dorsal
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horn, which has important implications for the therapeu-
tic control of pathological pain.
SP drives glutamate-independent feed-forward 
inhibition
The neuronal network in the spinal dorsal horn is
extremely complex. Within this circuit, inhibitory
interneurons containing GABA and/or glycine play
important roles in controlling network excitability. Acti-
vation of these neurons can initiate feedback inhibition
and feed-forward inhibition, which are believed to be crit-
ical for the fine tuning of sensory information at the spi-
nal level [10]. SP and glutamate, present in some primary
afferent fibers that respond to painful stimuli, can medi-
ate excitatory responses in postsynaptic dorsal horn neu-
rons [1,11]. Although it had been shown that glutamate
can bind to receptors on GABA and glycine-releasing
interneurons to decrease nociceptive transmission, the
possibility that SP could also drive inhibitory activity in
the spinal cord dorsal horn had not been explored.
Gu and colleagues stimulated the dorsal root of the spinal
cord, which contains primary afferent fibers, with high
frequency stimulation to cause the release of both SP and
glutamate in the presence of N-methyl-D-aspartate
(NMDA) receptors and non-NMDA receptors antagonists.
They found a robust and long-lasting increase in both the
frequency and amplitude of spontaneous inhibitory post-
synaptic currents (sIPSCs). Similar results were obtained
with chemical stimulation using capsaicin, which also
excites primary afferent fibers to release both glutamate
and SP [9]. This increase in sIPSCs when glutamate-medi-
ated excitatory responses were blocked suggests that gluta-
mate-independent feed-forward inhibition exists in the
dorsal horn.
Could SP be responsible for glutamate-independent feed-
forward inhibition? First, among different neuropeptides
such as galanin, neuropeptide Y, somatostatin, calcitonin
gene-related peptide and SP tested, only SP enhanced the
frequency and amplitude of sIPSCs. These results demon-
strate that the effect of SP is selective. Second, application
of NK1R antagonists blocked both electrical and chemical
stimulation-induced increases of sIPSCs. Third, exoge-
nously applied SP- or stimulation-induced increases of
sIPSCs were abolished in NK1R knockout (NK1R-/-) mice.
Taken together, these results demonstrate that increases of
SP can drive inhibitory activity in the dorsal horn of spinal
cord.
To further explore the neuronal mechanisms underlying
SP-driven feed-forward inhibition, pharmacological tools
were used to show that pertussis toxin-sensitive G proteins
such as Gi and Go are involved in SP-driven feed-forward
inhibition. Moreover, GIN mice, a strain of transgenic
mice that express enhanced green fluorescent protein in
GABAergic neurons, were used to show that SP can
directly excite some GABAergic neurons by inducing pro-
longed depolarization, firing of action potentials, and
increases of intracellular Ca2+. Since SP had no effect on
both miniature inhibitory postsynaptic currents (mIPSC)
and evoked inhibitory postsynaptic currents (eIPSC), SP-
driven feed-forward inhibition is more likely due to the
direct excitation of GABAergic interneurons by SP releas-
ing primary afferent fibers than to action potential-inde-
pendent modulation of activity within the synapse.
SP-driven feed-forward inhibition is summarized in Fig-
ure 1. The intense painful stimulation of primary affer-
ents, mostly Aδ- and C- fibers, induces the release of both
glutamate and SP, mainly in lamina I and V. In lamina I,
SP release activates projection neurons that relay pain-
Schematic diagram of SP-driven feed-forward inhibition in  lamina V of the spinal cord dorsal horn Figure 1
Schematic diagram of SP-driven feed-forward inhibi-
tion in lamina V of the spinal cord dorsal horn. Sen-
sory information starts from dorsal root ganglion (DRG) 
neurons, is relayed by spinal cord dorsal horn neurons and 
then is projecting to the brain. The intense painful stimulation 
of primary afferent, mostly Aδ- and C- fibers, induced the 
release of SP in lamina I and V. On the one hand, SP directly 
excites projection neurons in laminar I, thereby inducing pro-
nociceptive response. On the other hand, SP in laminar V 
excites inhibitory interneurons in lamina V, through NK1 
receptor (NK1R) and the following signaling pathway 
involved pertussis toxin-sensitive Gi/Go protein and possible 
downstream targets Ca2+ or K+ channels. The firing of these 
interneurons releases GABA and/or glycine, activate GABAA 
receptor (GABAAR) and/or glycine receptor (GlyR), and ini-
tiates feed-forward inhibition in the projection neurons 
ascending to the brain. The inhibitory interneuron is in green 
and the projection neuron is in red.Molecular Pain 2005, 1:34 http://www.molecularpain.com/content/1/1/34
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related information to higher centers in the nervous sys-
tem to process the different qualities of the stimulus. In
lamina V, SP binds pertussis toxin-sensitive Gi/Go-cou-
pled NK1R on inhibitory interneurons, which leads to a
cascade of downstream events that may result in changes
in the activity of non-selective cation channels or inwardly
rectifying potassium channels [12] ultimately leading to
GABA and/or glycine release. This could initiate feed-for-
ward inhibition in the projection neurons and probably
feed-back inhibition on the primary afferent fibers.
Different temporal phases between SP- and 
glutamate-driven feed-forward inhibition
Even though SP coexists with glutamate in primary nocic-
eptive afferent synaptic terminals, their roles in various
pain conditions may be distinct considering that higher
frequencies of primary afferent stimulation are required to
evoke the release of SP compared to glutamate [13]. Con-
sistent with this idea, previous electrophysiological stud-
ies reported that activation of these fibers produced two
phases of excitatory postsynaptic potentials (EPSPs), a fast
EPSP mediated by non-NMDA receptors and a slow EPSP
possibly mediated by the NK1R and NK2R [1,14]. There-
fore, it is conceivable that SP-driven feed-forward inhibi-
tion and glutamate-driven feed-forward inhibition have
different temporal phases.
To address this issue, Gu and colleagues first studied SP-
driven feed-forward inhibition in the absence of gluta-
mate receptor antagonists [9]. Their results showed that
high frequency stimulation induced a robust and long-
lasting increase in sIPSCs in wild-type mice but not in
NK1R-/-  mice. However, electrical stimulation-induced
immediate eIPSCs, which could be blocked by glutamate
receptor antagonists and are believed to be glutamate-
driven feed-forward inhibition, were similar between
wild-type and NK1R-/- mice. Taken together, these results
provide evidence for a long-lasting, glutamate-independ-
ent SP-driven feed-forward inhibition that is distinct from
the immediate pulse-by-pulse glutamate-driven feed-for-
ward inhibition.
Functional significance of SP-driven feed-
forward inhibition
After confirming the existence of the SP dependent feed-
forward inhibition as well as delineating its distinct tem-
poral phase, Gu and colleagues searched for the func-
tional significance of the SP-driven feed-forward
inhibition in the spinal cord dorsal horn. They hypothe-
sized that the SP-driven feed-forward inhibition may serve
to balance neuronal activity by counteracting SP-medi-
ated excitatory nociceptive responses. This hypothesis
challenges the traditional role of SP as a purely "pro-pain"
substance in favor of a more homeostatic role.
A clever set of experiments were devised to address this
question. First, SP-mediated nociceptive transmission in
the superficial dorsal horn was blocked with a selective
lesion of NK1R-expressing neurons using an intrathecal
injection of SP-conjugated saporin (SP-SAP) [17,18]. It is
important to note that the SP-SAP injection does not
cause cytotoxicity in lamina V neurons so the SP-driven
feed-forward inhibition remained intact. If an antinocice-
ptive role for SP-driven feed-forward inhibition exists, the
activation of SP release would have an analgesic effect in
SP-SAP injected animals but blocking SP transmission
would result in behavioral sensitization in SP-SAP
injected animals.
Behavior responses to nociceptive heat stimuli were stud-
ied in SP-SAP treated animals after capsaicin treatment
and intrathecal application of NK1R antagonists, resulting
in two major findings [9]. First, capsaicin-induced behav-
ioral sensitization in control animals was attenuated in
SP-SAP treated animals consistent with the role of SP
transmission in the superficial laminae as being "pro-
pain". Second, NK1R antagonists reduced behavioral sen-
sitization in the control group whereas the opposite effect
was found in SP-SAP treated rats that support a possible
antinociceptive role for SP in lamina V, probably through
feed-forward inhibition. These results may explain hyper-
stimulation-induced analgesia, in which pain is control-
led through additional painful stimulation or through
counter irritation [9,19], and the lack of an analgesic effect
of NK1R antagonists administered in clinical trials [5].
This study portrays SP as a double-edged sword for pain
transmission, SP's actions may depend both on the loca-
tion of release (lamina I vs lamina V) and an the type of
neuron it synapses with (projection neurons vs inhibitory
neurons).
Future directions
The elegant study by Gu and colleagues proposes a novel
cellular mechanism for the neurokinin system in pain
transmission and modulation. Dissecting its intricacies
will not only contribute to a better understanding of how
somatosensory inputs, including pain information, are
coded within the spinal dorsal horn, but may also foster
the development of more efficacious treatments for pain
control.
Due to the important implications of SP-driven feed-for-
ward inhibition in nociceptive transmission, some limita-
tions of these findings need to be addressed. (1) SP can be
released from at least three different sources: primary
afferent fibers, descending projections fibers and local
neurons. The current study uses dorsal root stimulation so
it is likely that the primary afferents are the cause of the SP
release [20,21]. Since it is possible that SP has a different
function depending on its source, this study cannot ruleMolecular Pain 2005, 1:34 http://www.molecularpain.com/content/1/1/34
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out the other potential actions of SP when it is released
from local neurons or descending terminals. (2) Activa-
tion of the NK1R in lamina V induced interneuronal
depolarization and firing that was not due to action
potential-independent synaptic transmission. Therefore,
these receptors are unlikely to be localized in the presyn-
aptic terminal. It would be interesting to investigate two
related issues. One is the exact location of NK1Rs on the
neuron, since some studies report that NK1Rs are postsy-
naptically or extrasynaptically located [22]. The other
issue is the molecular mechanism for SP induction of
interneuronal excitability. It is thought that SP might
directly induce a postsynaptic current or indirectly modu-
late various receptors and channels. The Gi/Go-coupled
NK1R is reported to activate phospholipase A2 and mobi-
lize arachidonic acid [23]. The final targets for the signal-
ing pathway initiated by SP binding to NK1R to result in
SP-driven feed-forward inhibition in the spinal cord dor-
sal horn are still a mystery. (3) Although SP and NKA are
synthesized together, they affect spinal nociception in dif-
ferent ways [24, 25]. Still, it cannot be ruled out that NKA
might play a role in SP-driven feed-forward inhibition.
The study excludes the possible involvement of neuroki-
nin B (NKB) in SP-driven feed-forward inhibition since
the NK3R (the receptor for NKB) antagonist did not sig-
nificantly attenuate capsaicin-induced increases of sIPSCs.
(4) This study showed that a long lasting increase in sIP-
SCs is SP-dependent but glutamate-independent. This
conclusion is based on pharmacological studies using
ionotropic glutamate receptor antagonists. However,
whether metabotropic glutamate receptors are involved in
SP-driven inhibition remains unknown. The authors can-
not prove without a doubt that SP-driven feed-forward
inhibition is glutamate independent without first exclud-
ing the potential role of metabotropic glutamate recep-
tors.
Although the complexity of nociceptive transmission and
modulation in the spinal cord make it difficult to address
all questions in a single model, we believe the description
of a SP-driven feed-forward inhibition to be a crucial find-
ing towards the understanding of the role of SP in sensory
transmission, modulation and plasticity.
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